America's bull market gets vertigo

America's benchmark S&P 500 stockmarket index has been in a bull market since March 2009 – or just over 3,400 days. It is only 50 days short of the longest post-1945 bull run, October 1990 to March 2000.

903_MW_P06_Markets

A hill to climb: European cars face US tariffs

US stocks are heading for a post-war record. The benchmark S&P 500 index, which sets the tone for the rest of the world, has been in a bull market since March 2009 or just over 3,400 days, as stockbroker AJ Bell points out. It is only 50 days short of the longest post-1945 bull run, October 1990 to March 2000. And having risen by 400%, it has easily eclipsed the 283% average rise of the ten previous post-war bull runs. It may well get through the next three months without slipping by 20% which would constitute a bear market and thus break the record. But then? "The list of headwinds is long and daunting," says Fidelity's Tom Stevenson in The Daily Telegraph.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Explore More
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.